The U.S. Food and Drug Administration on Tuesday gave a green light to Eli Lilly’s donanemab for patients with early Alzheimer’s, making it the second approved drug for slowing the progress of the brain-wasting disease. The approval for the drug branded Kisunla is in line with the recommendations of the agency’s outside experts who unanimously…
By Milana Vinn (Reuters) – Private equity firm Vista Equity is in talks to cede control of its company Pluralsight to lenders, according to three people familiar with the matter and fund documents reviewed by Reuters. The financial information in the documents sheds light on how Pluralsight is set to become the first major debt…
By Jonathan Stempel NEW YORK (Reuters) – Progressive agreed to pay $48 million to settle a class action lawsuit accusing the insurer of systematically undervaluing the claims of New York drivers whose vehicles were wrecked. A preliminary settlement of the proposed class action was filed on Monday night in federal court in Manhattan, and requires…
(Reuters) – Walmart has held talks with potential buyers to sell its already shuttered medical clinics, Fortune reported on Tuesday, citing multiple sources familiar with the matter. In April, Walmart decided to close all 51 of its health clinics and shut its virtual healthcare operations, saying it could not see them as a sustainable business…
